Clinical Trial Update: Open Label Study to Evaluate Ciprofloxacin/Celecoxib Combination in Patients With ALS [Phase 2]

View source ↗

Summary

Phase 2 open-label trial evaluating a ciprofloxacin/celecoxib combination in patients with amyotrophic lateral sclerosis (ALS) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Ciprofloxacin/Celecoxib combination

Snippet

Sponsor: NeuroSense Therapeutics Ltd. | Conditions: Amyotrophic Lateral Sclerosis, ALS | Phase 2 | Status: COMPLETED